The Medical Device Business Journal — Medical Device News & Articles | MassDevice
A federal judge in New York dismissed a lawsuit accusing Stryker Corp. (NYSE:SYK) subsidiary Howmedica Osteonics of manufacturing a defective knee implant.
Beverly Maxwell had a total knee replacement in June 2004, using Howmedica’s Duracon Total Knee System. Maxwell developed an allergic reaction to the nickel contained in the Duracon device, which was replaced in August 2005 using a low-nickel Smith & Nephew (NYSE:SNN) Genesis II implant.
Covidien plc (NYSE:COV) settled a patent infringement lawsuit brought against its corporate prececessor, Tyco Healthcare Group LP, by Kimberly-Clark Worldwide Inc. (NYSE:KMB) over endotracheal tubes.
The Mansfield, Mass.-based medical products giant and its Irving, Texas-based competitor agreed to settle the case, each paying their own legal fees, according to court documents.
Kimberly-Clark filed suit in the U.S. District Court for Eastern Wisconsin in April 2009, alleging that Covidien subsidiary Mallinckrodt’s SealGuard and SealGuard Evac endotracheal tubes infringe a patent for its Microcuff product.
In Iron Man 2, our hero Tony Stark manages to save the world from the military-industrial complex and create an entirely new chemical element, but still suffers through the inconvenient and mildly painful tribulation of numerous pin-prick blood tests a day.
Draper Laboratories, right down the street from Stark’s alma mater, MIT, has a solution. A scientist at the lab has successfully demonstrated an implantable nanosensor that changes color as chemical concentrations fluctuate in the bloodstream.
A federal judge in Michigan tossed a whistleblower lawsuit against Stryker Corp. (NYSE:SYK) that accused the company of a kickbacks scheme, but gave the plaintiffs a window to amend their complaint.
Judge Robert Jonker of the U.S. District Court for Western Michigan ruled that Robert Laucirica and the U.S. government failed to prove their contention that Stryker sales reps initiated a kickbacks scheme with Dr. Hari Parvataneni, an orthopedic surgeon at the University of Miami’s Jackson Memorial Hospital.
The U.S. Dept. of Justice demanded documents from St. Jude Medical Inc. (NYSE:STJ) about its implantable cardiac defibrillator business, according to a regulatory filing.
The "civil investigative demand" from the Justice Dept. sought documents and "sets forth interrogatories" about "various indications for ICDs and a National Coverage Decision issued by Centers for Medicare and Medicaid Services," according to the filing.
By Mary Vanac
The Cleveland Clinic admitted that a former staff physician and inventor, Dr. Jay Yadav, did not run afoul of the health system’s conflicts of interest policy, as it claimed in 2006 in declining to renew Yadav’s employment contract.
A federal judge in Boston tossed a class action securities lawsuit filed against Boston Scientific Corp. (NYSE:BSX) accusing the company of misleading investors about problems with its Taxus Express drug-eluting stent.
A federal judge today rejected a $296 million plea agreement between the U.S. Justice Dept. and Boston Scientific Corp. (NYSE:BSX) subsidiary Guidant Corp. over faulty implantable defibrillators.
Inverness Medical Innovations Inc. (NYSE:IMA) and a Chinese medical products distributor, Chinmax Medical Products Inc., are embroiled in a dispute over the rights to sell Inverness subsidiary Biosite’s Triage line of diagnostic products in the People’s Republic.
Shanghai-based Chinmax claims to hold the exclusive right to distribute the Triage brand in China and filed suit in March against Inverness Medical Beijing Co. Ltd. and another distributor, Shanghai Tongwei Medical Device Co. Ltd., accusing them of infringing that right, according to a press release.
John Paulson, the billionaire whose hedge fund is the largest shareholder of Boston Scinetific Corp. (NYSE:BSX) stock, is seeking shelter from the fallout billowing around his head after he was named but not charged in a Securities & Exchange Commission indictment of Goldman Sachs Co. over sub-prime mortgages.
The SEC filed a civil suit against Goldman Sachs April 16, accusing the firm of misleading the public with statements concerning the sub-prime mortgage securities whose collapse helped precipitate the near-meltdown of the global financial market.
A federal judge in Texas tossed a lawsuit against Stryker Corp. (NYSE:SYK) and its Howmedica Osteonics subsidiary over an allegedly defective hip implant, ruling that federal law preempts the suit.
